Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately. Vlad Coric is the Chairman and Chief Executive Officer ...

Vertex continues to capitalize on its leadership in cystic fibrosis (CF) treatments, where its blockbuster drug Trikafta is ...

By putting people at the center of innovation, TX not only drives growth but also fosters loyalty, engagement and long-term ...

LinkedIn just released its annual list of Top Companies in the UK – ranking the best workplaces for career growth, from ...

Seven of the world’s 10 most valuable companies have launched platform businesses, as have over 60% of unicorn startups. Many ...

SpotDraft, an AI-driven contract lifecycle management (CLM) platform for in-house legal teams, raised $54 million in Series B funding led by Vert ...

Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

Previous experience also includes stints at Heidrick & Struggles, Hunt Oil Company, and Shell ... not just how the finance team needs to execute certain functions, but the skills they need to do so.

This expansion of the addressable market underscores the company’s continued growth potential in its core therapeutic area. Vertex’s financial performance has been robust, with the company raising its ...